期刊文献+

武汉协和医院354例肝硬化患者流行病学情况及发病的时间规律性研究 被引量:7

Epidemiology and seasonal variation in the onset of cirrhosis:analysis of 354 cases in Wuhan union hospital
原文传递
导出
摘要 [目的]探讨武汉协和医院354例肝硬化患者流行病学情况及发病时间是否存在时间规律性,为进一步防治肝硬化提供依据。[方法]回顾性分析武汉协和医院2009年1月~2014年1月354例肝硬化患者的临床资料,分析其发病的时间规律性。[结果]本组患者男206例,占58.19%;女148例,占41.81%;发病年龄51~60岁为高发年龄段;病因以乙型病毒性肝炎最多见,占45.19%;肝硬化最常见的并发症是门静脉高压(96.61%);患者就诊的主要原因是上消化道出血(40.11%)。肝硬化的总体发病时间以3月份最多。[结论]肝硬化存在3月份发病率上升的时间规律性,乙肝肝硬化是肝硬化的主要病因之一,防治病毒性肝炎是预防肝硬化的重要手段。积极防治肝硬化并发症上消化道出血是延长患者生命最重要的环节。 [Objective]To provide basis for the prevention and treatment for cirrhosis via exploring the epidemiology and the possible existence of a seasonal variability in its onset. [Methods]354 hospitalized ca- ses of cirrhosis, from January 2009 to January 2014, were retrospectively analyzed for seasonal variation. [Results]The data include 206 male patients(58.19%)and 148 female patients(41.81%). High incidence falls in the age range from 51 to 60 years. Viral hepatitis B is the most common cause of cirrhosis(45.19%); The biggest complication(96.61%)is portal hypertension~ The patients were mainly hospitalized for upper gastrointestinal hemorrhage(40.11 %). There was significant difference in overall incidence of cirrhosis on- set time,March had the highest incidence. [Conclusion]Seasonal pattern in the onset of cirrhosis, with a peak in March, is confirmed. Hepatitis B induced cirrhosis is the main cause of the incidence in Hubei, therefore prevention and treatment of viral hepatitis is an important approach for preventing cirrho- sis. Prevention and treatment of its complication, upper gastrointestinal hemorrhage, is the key that pro- longs life of patients.
出处 《中国中西医结合消化杂志》 CAS 2018年第1期31-34,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 国家自然科学基金(No:81102692) 湖北省自然科学基金(No:2016CFB684) 武汉市青年科技晨光计划(No:2017050304010279) 华中科技大学自主创新基金青年教师基金资助(No:2015QN203)
关键词 肝硬化 流行病学 季节规律 cirrhosis epidemiology seasonal variation
  • 相关文献

参考文献1

二级参考文献26

  • 1G. Musso,M. Cassader,F. Rosina,R. Gambino.Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials[J]. Diabetologia . 2012 (4)
  • 2Etsuko Hashimoto,Satoru Yatsuji,Maki Tobari,Makiko Taniai,Nobuyuki Torii,Katsutoshi Tokushige,Keiko Shiratori.Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis[J]. Journal of Gastroenterology . 2009 (19)
  • 3Christi A. Matteoni *,Zobair M. Younossi *,Terry Gramlich ?,Navdeep Boparai §,Yao Chang Liu ∥,Arthur J. McCullough ?.Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity[J]. Gastroenterology . 1999 (6)
  • 4Camilo Boza MD,Arnoldo Riquelme MD,Luis Iba?ez MD,Ignacio Duarte MD,Enrique Norero MD,Paola Viviani MD,Alejandro Soza MD,Jose Ignacio Fernandez MD,Alejandro Raddatz MD,Sergio Guzman MD,Marco Arrese MD.Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass[J]. Obesity Surgery . 2005 (8)
  • 5Anna Ludovica Fracanzani,Larry Burdick,Sara Raselli,Paola Pedotti,Liliana Grigore,Gennaro Santorelli,Luca Valenti,Alessandra Maraschi,Alberico Catapano,Silvia Fargion.Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease[J]. The American Journal of Medicine . 2008 (1)
  • 6Ziya Omer,Sevki Cetinkalp,Murat Akyildiz,Funda Yilmaz,Yucel Batur,Candeger Yilmaz,Ulus Akarca.Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease[J]. European Journal of Gastroenterology & Hepatology . 2010 (1)
  • 7John Willy Haukeland,Zbigniew Konopski,Heidi Beate Eggesb?,Hilde L?land von Volkmann,Gabriele Raschpichler,Kristian Bj?ro,Terese Haaland,Else Marit L?berg,K?re Birkeland.Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial[J]. Scandinavian Journal of Gastroenterology . 2009 (7)
  • 8M. J. Armstrong,D. D. Houlihan,I. A. Rowe,W. H. O. Clausen,B. Elbr?nd,S. C. L. Gough,J. W. Tomlinson,P. N. Newsome.Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program[J]. Aliment Pharmacol Ther . 2012 (2)
  • 9Zhi-Jiang Zhang,Zhi-Jie Zheng,Rong Shi,Qing Su,Qingwu Jiang,Kevin E. Kip.Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis[J]. The Journal of Clinical Endocrinology & Metabolism . 2012 (7)
  • 10Suzanne E. Mahady,Angela C. Webster,Sarah Walker,Arun Sanyal,Jacob George.The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis[J]. Journal of Hepatology . 2011 (6)

共引文献13

同被引文献98

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部